Nalbuphine Hydrochloride Injection, Solution
Product Images NDC 0404-9918

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nalbuphine Hydrochloride (NDC 0404-9918). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Formula1.jpg (Formula1)
HCI (Human-Computer Interaction) is a field of study which focuses on the design, evaluation, and implementation of interactive computing systems for human use. It involves understanding the needs and behaviors of users and designing interfaces that are user-friendly and efficient. The goal of HCI is to make technology more accessible and intuitive for people, regardless of their skill level or experience.*
FDA Label Image

Image1.jpg (Image1)

FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
The text is a description of Nalbuphine Hydrochloride, a drug for injection that comes in single-dose ampules of 10 mg. It can be administered intravenously, intramuscularly, or subcutaneously. It should be kept in a protected area away from light and children, and unused portions should be disposed of promptly. Store it at room temperature and follow the manufacturer's instructions. The information includes the lot number, packaging details, and expiration date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.